Trial intelligence / Profile preview

ADICROHN3: Cryopreserved Autologous SVF for Refractory Ano-perineal Fistulas in Crohn's Disease

NCT07629245Phase 2Recruiting

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Dec 2025
Primary completion
Jun 2028
Countries
1
01

Overview

A Phase 2 trial of autologous adipose stromal vascular fraction in Crohn's disease, sponsored by Assistance Publique-Hôpitaux de Marseille. Started Dec 2025; status: recruiting.

02

Drugs

autologous adipose stromal vascular fraction
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT07629245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07629245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call